News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MIV Therapeutics Inc. (MIVT) VESTAsync™ Drug-Eluting Stent Trials Progress



9/15/2008 9:54:22 AM

ATLANTA--(BUSINESS WIRE)--MIV Therapeutics, Inc. (OTCBB: MIVI, www.mivtherapeutics.com), a leading developer of next-generation coatings and advanced drug-delivery systems for cardiovascular stents and other implantable medical devices, provides corporate update.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES